False Negative HSV2 Test Results in Clinically Diagnosed Patients
When a patient is clinically diagnosed with HSV2 but laboratory tests come back negative, this is most likely due to the limitations of serologic testing, timing of the test, or sampling issues. 1
Reasons for False Negative HSV2 Test Results
Testing Method Limitations
- PCR testing from active lesions is the gold standard with >90% sensitivity and specificity, but can still miss infections 1
- Serologic tests have significant limitations:
Timing Issues
- Window period: Serologic testing should not be repeated until at least 12 weeks after exposure to determine if HSV-2 was acquired 2, 1
- Testing during the healing phase of lesions can yield false negatives 1
Sampling Issues
- Inadequate sample collection from lesions
- Improper specimen handling or storage
- Testing inappropriate sites that don't have active viral shedding 2, 1
Recommended Approach for Discordant Results
Step 1: Evaluate the Clinical Presentation
- Assess if the clinical presentation is truly consistent with HSV2 (clustered vesicles, painful ulcers, recurrent nature)
- Consider alternative diagnoses that can mimic genital herpes
Step 2: Determine the Type of Test Used
- If serologic testing was used, consider the limitations mentioned above
- If PCR or viral culture was used, evaluate sampling technique and timing
Step 3: Recommended Testing Algorithm
For patients with active lesions:
For patients without active lesions:
For patients with low positive HSV-2 serologic results (index value <3.0):
Important Caveats
- Even with index values ≥3.0, false positives have been reported 2, 1
- Persons with HSV-1 infection are more likely to have false-positive HSV-2 test results with low index values 2
- Commercial type-specific HSV antibody assays can be false negative in 12-30% of patients with recurrent HSV DNA positive genital lesions 3
- Using multiple testing methods increases diagnostic accuracy - in one study, 88-90% of patients with recurrent HSV had antibodies detected when using at least one of three different antibody tests 3